Fourier Intelligence
Chinese maker of rehab robots and GR series humanoid robots, split into two units in 2024.
Fourier's rehab business has real customers and paperwork behind it; its humanoid line is racing Unitree and UBTECH on price with no such protection yet.
Fourier Intelligence runs two separate businesses: one sells physical therapy robots to hospitals and clinics (over 2,000 customers, hard to displace), and one builds general-purpose humanoid robots (GR-1, GR-2, GR-3) that compete directly with Unitree and UBTECH, who already sell similar robots for less money. The company's $3.6 to $3.9 billion value depends almost entirely on the humanoid robots becoming a big business, but those robots have no real protection against copy-cats, AI models like DeepSeek are becoming standard parts that any company can use, and NVIDIA's training tools let competitors catch up fast. The one thing that could turn this around: Fourier could stop chasing the same mass-market humanoid race as everyone else and instead focus on eldercare or medical robots, where its hospital reputation and regulatory approvals actually matter, and where the Malaysia government contract (worth tens of millions) proves the playbook works.
GR-3 eldercare rollout expands beyond the Malaysia Perkeso contract to new institutional buyers. Would show the rehab-channel moat is transferring to humanoids, not just the generic humanoid race.
Fourier files for a Hong Kong HKEX listing after the July 2026 listing reform. Would show a concrete IPO path separate from private valuation claims.
- Series E raised $109-110M
- Series E+ added CNY 300M (~$41-43M)
- Installed base: 3,000+ institutions, 40 countries
- Humanoid GR-series lacks price or scale differentiation against Unitree and UBTECH.
- AI interaction layer for GR-3 depends on outsourced DeepSeek and NVIDIA Isaac infrastructure shared with rivals.
- No audited revenue or confirmed profitability disclosed; company relies on near-annual private funding rounds.
- US Charlotte, NC expansion exposes company to geopolitical export-control risk given Chinese ownership.
- Rehab division moat (2,000+ institutions, ~200 patents) may be structurally strong but insufficient alone to support company-wide ambitions.
| Rival | Direction | Evidence |
|---|---|---|
| Unitree Robotics | losing to | Unitree G1 lists at $13,500 vs Fourier's unlisted institutional pricing, as of 2026-07-16 |
| UBTECH Robotics | losing to | Walker S logged ~$112M cumulative industrial orders across BYD, Foxconn, as of 2026-05-19 |
| AgiBot | losing to | AgiBot shipped 5,100+ units and ~$140M 2025 revenue per market report, 2026-05-19 |
| Tesla Optimus | contesting | Named as adjacent incumbent threat in general-purpose humanoid market |
- Is Fourier Intelligence profitable?
- Fourier Intelligence is private and does not disclose audited financials. In 2023 its overseas rehab division reportedly grew over 50% and made up about 10% of total revenue, per aiwiki.ai (2026-06-21), but no confirmed profit or loss figures exist for the company overall.
- Who owns Fourier Intelligence?
- Fourier Intelligence is privately held, founded in Shanghai in 2015 by Alex Gu and Zen Koh. Investors include SoftBank Vision Fund 2 (Series D, RMB 400M, Jan 2022), Saudi Aramco-linked Prosperity7 Ventures, IDG Capital, and Zhejiang Runyang, per 36kr and sacra.com. No IPO has been filed as of July 2026.
- Who is Fourier Intelligence's biggest competitor?
- Unitree Robotics and UBTECH Robotics are Fourier Intelligence's closest humanoid rivals. Unitree undercuts on price (G1 humanoid listed around $13,500 as of 2026-07-16), while UBTECH's Walker S has logged roughly $112M in cumulative industrial orders across BYD and Foxconn as of 2026-05-19.
- Could AI replace Fourier Intelligence's robots?
- Fourier's GR-3 humanoid outsources its conversational AI layer to DeepSeek and trains on NVIDIA Isaac, shared infrastructure also used by rivals, per owler.com (2026-04-20) and aiwiki.ai. This makes its general humanoid line vulnerable to commoditization, though its clinical rehab data and hospital relationships are harder for AI-only entrants to replicate.
- Has Fourier Intelligence filed for an IPO?
- No confirmed IPO filing for Fourier Intelligence exists as of July 2026. Hong Kong's HKEX announced major IPO reforms on 2026-07-24 (scmp.com) that could ease a future listing path, but the company has not been found in CSRC Hong Kong filing tables as of that date.
- What is Fourier Intelligence's GR-3 robot used for?
- GR-3, unveiled August 6, 2025, is Fourier's care-centric humanoid: 165cm tall, 55 degrees of freedom, with a 4-mic array and 31 pressure sensors for eldercare interaction, built with a DeepSeek AI partnership (prnewswire.com, owler.com). It debuted in the US at CES 2026 on 2026-01-07.
- 2026-07-20Showed embodied-AI home-companionship demo for GR-3 at WAIC
- 2026-06-11Signed Malaysia Perkeso rehab center contract worth tens of millions of yuan
- 2026-04-20Announced US headquarters partnership in Charlotte, North Carolina
- 2026-01-07GR-3 made US debut at CES 2026 with companion-robot concept
- 2025-08-06Unveiled GR-3 care-centric humanoid with DeepSeek AI partnership
- 2025-08-01Closed Series E+ CNY 300M round from Zhejiang Runyang
- 2025-01-06Closed Series E round of roughly RMB 800M ($109-110M)
- 2024-09Unveiled GR-2 humanoid, 175cm, 63kg, 53 degrees of freedom
- 2024-07Rebranded and split into Fourier (humanoids) and Fourier Rehab
- 2023-07Unveiled GR-1, first full-size humanoid, at WAIC
- Fourier (company)
- Fourier Intelligence (2026-06-21)
- Fourier has completed a new round of financing
- Fourier Intelligence Series E (2025-01-06)
- Fourier news & analysis (2025-07-31)
- Fourier Stock Price, Funding, Valuation, Revenue & Financial Statements (2026-05-09)
- Fourier Intelligence Company Profile
- The Trio Behind China's Humanoid Push (2025-08-21)
- Fourier's Humanoid Robots... Perkeso Rehab Center in Malaysia (2026-06-11)
- Meet GR-3 (2025-08-06)
- Figure 03 vs Unitree H2 (2026-07-16)
- Global Commercial Humanoid Robotics Market Research (2026-05-19)